Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00735514 · ClinicalTrials.gov registry record
Compliance to Vaginal Dilation Therapy in Patients Who Have Undergone Radiation Therapy For Stage IB, Stage IIA, Stage IIB, Stage IIIA, or Stage IIIB Cervical Cancer or Stage IA, Stage IB, Stage IIA, or Stage IIB Endometrial Cancer
A clinical trial, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- 83
- Enrollment target
NCT00735514 is a clinical trial that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 83 participants.
The verdict
NCT00735514 has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- 83 participants
- Enrollment target
Study Summary
RATIONALE: Understanding how well patients comply with their treatment regimen may help doctors determine best treatment and ongoing care for future patients. PURPOSE: This phase I study is looking at compliance with vaginal dilation therapy in women who have undergone radiation therapy for stage IB, stage IIA, stage IIB, stage IIIA, or stage IIIB cervical cancer or stage IA, stage IB, stage IIA, or stage IIB endometrial cancer.
Interventions
- OTHER questionnaire administration
- PROCEDURE psychosocial assessment and care
- PROCEDURE management of therapy complications
- PROCEDURE assessment of therapy complications
- BEHAVIORAL compliance monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2008-07 |
| Est. Completion | 2010-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00735514
The ClinicalTrials.gov registry entry for NCT00735514 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 83 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which questionnaire administration is the first listed.
NCT00735514 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00735514 about?
NCT00735514 is a clinical study titled "Compliance to Vaginal Dilation Therapy in Patients Who Have Undergone Radiation Therapy For Stage IB, Stage IIA, Stage IIB, Stage IIIA, or Stage IIIB Cervical Cancer or Stage IA, Stage IB, Stage IIA, or Stage IIB Endometrial Cancer". RATIONALE: Understanding how well patients comply with their treatment regimen may help doctors determine best treatment and ongoing care for future patients. PURPOSE: This phase I study is looking at compliance with vaginal dilation therapy in women who have undergone radiation therapy for stage I...
What is the current status of trial NCT00735514?
This trial is currently completed. The enrollment target is 83 participants. The study started on 2008-07. Estimated completion is 2010-05.
What interventions are being tested in trial NCT00735514?
The interventions under investigation include: questionnaire administration (OTHER), psychosocial assessment and care (PROCEDURE), management of therapy complications (PROCEDURE), assessment of therapy complications (PROCEDURE), compliance monitoring (BEHAVIORAL).
Who is sponsoring clinical trial NCT00735514?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.